BioStock: Allegro Investment Fund about the ownership in Alligator Bioscience

Recently, Allegro Investment Fund exceeded the 25 percent threshold in biotech company Alligator Bioscience. The US-managed investment fund has been a long time shareholder in Alligator and decided to increase its holdings significantly in connection with Alligator’s  rights issue in November 2021. BioStock reached out to founder Staffan Encrantz to hear more about Allegro and his vision for Alligator.

Read the interview with Allegro Investment Fund's founder Staffan Encrantz at biostock.se.

https://www.biostock.se/2022/03/allegro-investment-fund-about-the-ownership-in-alligator-bioscience/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/